Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded MGA’s Alex Brill submitted a letter in response to a request for information from the Federal Trade Commission. The FTC was looking for information regarding the business practices of pharmacy benefit...
New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition MGA has released a new report today, “Understanding Drug Rebates and Their Role in Promoting Competition,” authored by founder and CEO Alex Brill. Offering new analysis on the...
Conservative Thinkers Share Their Views for Biosimilars in a Post-ACA, BPCIA Landscape Allison Inserro | The Center for Biosimilars “Would legislators take the opportunity to redo some parts of the BPCIA, if they had the chance? Both [Alex] Brill and Hayes said...
